Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc. (PHBI) shows no detected cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the recent period. However, low signal in this window does not mean low risk; underlying vulnerabilities in capital structure, dilution patterns, or financing history may not yet be visible. The full $49 Report extends analysis to 12 months of SEC filings, adds a dilution risk score, contextualizes any 8-K events, and identifies AI-detected risk signals across financing and governance. This gives you the foundation needed to assess PHBI's true risk profile beyond surface-level compliance metrics.